Understanding the neurotransmitter pathology of schizophrenia: Selective deficits of subtypes of cortical GABAergic neurons

Journal of Neural Transmission

Volumn 109, Issue 5-6, 2002, Pages 881-889

  Reynolds, G P ^a   Beasley, C L ^a   Zhang, Z J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Calcium binding proteins; Cerebral cortex; GABA; Human brain; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALBINDIN; CALRETININ; PARVALBUMIN;

ARTICLE; BRAIN NERVE CELL; CELL DENSITY; CONTROLLED STUDY; DEPRESSION; ENTORHINAL CORTEX; GABAERGIC SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTERNEURON; MANIC DEPRESSIVE PSYCHOSIS; NERVE CELL DIFFERENTIATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL CORTEX;

BIPOLAR DISORDER; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CEREBRAL CORTEX; DEPRESSION; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURONS; NEUROTRANSMITTER AGENTS; PARVALBUMINS; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 0036328050     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020200072     Document Type: Article

References (29)

1. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics
2. Deficits of [3H]D-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia
3. The medial temporal lobe in schizophrenia
4. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia
5. Heterogeneity of layer II neurons in human entorhinal cortex
6. Parvalbumin-immunoreactive neurons are reduced in the frontal cortex of schizophrenics
7. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium binding proteins
8. Quantitative cytoarchitectural analyses of the cerebral cortex of schizophrenics
9. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients
10. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia
11. Local circuit neurons of the prefrontal cortex in schizophrenia: Selective increase in the density of calbindin-immunoreactive neurons
12. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia
13. Recent advances in the phencyclidine model of schizophrenia
14. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia
15. Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia
16. Glutamate receptor dysfunction and schizophrenia
17. Increased dopamine-receptor sensitivity in schizophrenia
18. Cytoarchitectonic definition of prefrontal areas in the normal human cortex. I. Remapping of areas 9 and 46 using quantitative criteria
19. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia
20. GABAergic neuronal subtypes in the human frontal cortex - Development and deficits in schizophrenia
21. Dopamine receptors and schizophrenia: Drug effect or illness
22. Dopamine receptors and schizophrenia: The neuroleptic drug problem
23. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia
24. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: Selective losses of calcium binding protein immunoreactivity
25. Chronic antipsychotic drug administration alters calcium-binding protein levels but not GAD levels in the prefrontal cortex of the rat
26. Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: Ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures
27. Ontogeny of the calcium binding protein parvalbumin in the rat nervous system
28. The Stanley Foundation brain collection and neuropathology consortium
29. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia